Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan R Branch

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Langmuir : the ACS Journal of Surfaces and Colloids|September 11, 2014
Methacrylation induces rapid, temperature-dependent, reversible self-assembly of type-I collagenKathryn E Drzewiecki, Avanish S Parmar, Ian D Gaudet, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2009
Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cellsKelvin C Luk, Cheng Song, Patrick O'Brien, et al.
Expert Review of Cardiovascular Therapy|April 20, 2010
Shear stress and plaque developmentSaurabh S Dhawan, Ravi P Avati Nanjundappa, Jonathan R Branch, et al.
ACS Medicinal Chemistry Letters|August 23, 2021
Spirocyclic Thiohydantoin Antagonists of F877L and Wild-Type Androgen Receptor for Castration-Resistant Prostate CancerZhuming Zhang, Peter J Connolly, Luis Trabalón Escolar, et al.
Journal of Medicinal Chemistry|January 20, 2021
Discovery of JNJ-63576253: A Clinical Stage Androgen Receptor Antagonist for F877L Mutant and Wild-Type Castration-Resistant Prostate Cancer (mCRPC)Zhuming Zhang, Peter J Connolly, Heng Keang Lim, et al.
Molecular Cancer Therapeutics|March 2, 2021
Discovery of JNJ-63576253, a Next-Generation Androgen Receptor Antagonist Active Against Wild-Type and Clinically Relevant Ligand Binding Domain Mutations in Metastatic Castration-Resistant Prostate CancerJonathan R Branch, Tammy L Bush, Vineet Pande, et al.
Cancer Research Communications|August 7, 2023
The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate CancerLucie Van Emmenis, Sheng-Yu Ku, Kaitlyn Gayvert, et al.
Cell Chemical Biology|October 21, 2020
Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 InhibitorsAndré Richters, Shelby K Doyle, David B Freeman, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Langmuir : the ACS Journal of Surfaces and Colloids|September 11, 2014
Methacrylation induces rapid, temperature-dependent, reversible self-assembly of type-I collagenKathryn E Drzewiecki, Avanish S Parmar, Ian D Gaudet, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2009
Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cellsKelvin C Luk, Cheng Song, Patrick O'Brien, et al.
Expert Review of Cardiovascular Therapy|April 20, 2010
Shear stress and plaque developmentSaurabh S Dhawan, Ravi P Avati Nanjundappa, Jonathan R Branch, et al.
ACS Medicinal Chemistry Letters|August 23, 2021
Spirocyclic Thiohydantoin Antagonists of F877L and Wild-Type Androgen Receptor for Castration-Resistant Prostate CancerZhuming Zhang, Peter J Connolly, Luis Trabalón Escolar, et al.
Journal of Medicinal Chemistry|January 20, 2021
Discovery of JNJ-63576253: A Clinical Stage Androgen Receptor Antagonist for F877L Mutant and Wild-Type Castration-Resistant Prostate Cancer (mCRPC)Zhuming Zhang, Peter J Connolly, Heng Keang Lim, et al.
Molecular Cancer Therapeutics|March 2, 2021
Discovery of JNJ-63576253, a Next-Generation Androgen Receptor Antagonist Active Against Wild-Type and Clinically Relevant Ligand Binding Domain Mutations in Metastatic Castration-Resistant Prostate CancerJonathan R Branch, Tammy L Bush, Vineet Pande, et al.
Cancer Research Communications|August 7, 2023
The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate CancerLucie Van Emmenis, Sheng-Yu Ku, Kaitlyn Gayvert, et al.
Cell Chemical Biology|October 21, 2020
Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 InhibitorsAndré Richters, Shelby K Doyle, David B Freeman, et al.
Pageof 1